Capsule Summary Slidesets

Share

Program Content

Activities

LA CAB/RPV + LEN for HIV Treatment
LA CAB/RPV + LEN in People With HIV, Adherence Challenges, and INSTI/NNRTI Resistance Mutations
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 24, 2024

Expires: October 23, 2025

OPERA: LA CAB PrEP
OPERA: Real-world Experience With LA CAB PrEP
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 24, 2024

Expires: October 23, 2025

TRIO: Real-World LA CAB for PrEP
TRIO COHORT: Real-World LA CAB for PrEP Over the First 2 Years
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 25, 2024

Expires: October 24, 2025

CAPELLA: LEN Wk 156 Results
CAPELLA: Wk 156 Results With LA SC Lenacapavir in Persons Living With Multidrug-Resistant HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 30, 2024

Expires: October 29, 2025

Phase II ISL + LEN: Wk 48
Once-Weekly Oral ISL + LEN in Virologically Suppressed People Living With HIV: Wk 48 Results
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 14, 2024

Expires: November 13, 2025

LA CAB PrEP in Pharmacies
LA CAB PrEP in Community Pharmacy Setting: Wk 26 Acceptability and Feasibility Data
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 14, 2024

Expires: November 13, 2025

DOLCE: DTG/3TC and Low CD4 Count
DOLCE: DTG/3TC in Treatment-Naive People Living With HIV and Low CD4+ Cell Counts
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 15, 2024

Expires: November 14, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare